Evidence map›Paper›PMID 34098622›Full record

ArticleSalud publica de Mexico2021

On the increasing incidence of SARS-CoV- 2 in older adolescents and younger adults during the epidemic in Mexico.

Dalia Stern, Martin Lajous, Blanca De la Rosa, Edward Goldstein

Open access · diamondAbstract read
PubMed Publisher
In one paragraph

Article in Salud publica de Mexico, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Dalia SternCátedra Conacyt, Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico. dalia.stern@insp.mx.
Martin LajousCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico / Department of Global Health and Population, Harvard T.H. Chan School of Public Health. Boston, United States. mlajous@insp.mx.
Blanca De la RosaDirección General de Epidemiología, Dirección de Información Epidemiológica, Secretaría de Salud. Mexico City, Mexico. mlajous@insp.mx.
Edward GoldsteinCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health. Boston, United States. egoldste@hsph.harvard.edu.
Instituto Nacional de Salud Pública · MXCenter for Disease Dynamics, Economics & Policy · USDireccion General de Epidemiologia · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo estimate temporary changes in the inciden-ce of SARS-CoV-2-confirmed hospitalizations (by date of symptom onset) by age group during and after the national lockdown. MATERIALS AND

methodsFor each age group g, we computed the proportion E(g) of individuals in that age group among all cases aged 10-59y during the early lock-down period (April 20-May 3, 2020), and the corresponding proportion L(g) during the late lockdown (May 18-31, 2020) and post-lockdown (June 15-28, 2020) periods and computed the prevalence ratio: PR(g)=L(g)/E(g).

resultsFor the late lockdown and post-lockdown periods, the highest PR values were found in age groups 15-19y (late: PR=1.69, 95%CI 1.05,2.72; post-lockdown: PR=2.05, 1.30,3.24) and 20-24y (late: PR=1.43, 1.10,1.86; post-lockdown: PR=1.49, 1.15,1.93). These estimates were higher in individuals 15-24y compared to those ≥30y.

conclusionsAdolescents and younger adults had an increased relative incidence of SARS-CoV-2 during late lockdown and post-lockdown periods. The role of these age groups should be considered when implementing future pandemic response efforts.

Indexed as

AdolescentAdultAge DistributionChildCOVID-19HospitalizationHumansIncidenceMexicoMiddle AgedPrevalenceYoung Adult

Identifiers

PMID34098622
OpenAlexW3163476778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.